Santhera Pharmaceuticals (Schweiz) Company
 AG.png)
We are focusing on the development of treatments for neuromuscular and pulmonary diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF).